A Preclinical Investigation into the Effects of Aging on Dermal Hyaluronan Properties and Reconstitution Following Recombinant Human Hyaluronidase PH20 Administration
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Preclinical Investigation into the Effects of Aging on Dermal Hyaluronan Properties and Reconstitution Following Recombinant Human Hyaluronidase PH20 Administration
Authors
Keywords
-
Journal
Dermatology and Therapy
Volume 10, Issue 3, Pages 503-513
Publisher
Springer Science and Business Media LLC
Online
2020-05-03
DOI
10.1007/s13555-020-00380-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ENHANZE® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20
- (2019) Kenneth W. Locke et al. DRUG DELIVERY
- Overview of Antibody Drug Delivery
- (2018) Sahar Awwad et al. Pharmaceutics
- Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities
- (2018) Beate Bittner et al. BIODRUGS
- Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase
- (2016) Christopher C. DuFort et al. BIOPHYSICAL JOURNAL
- A time and motion study of subcutaneous versus intravenous trastuzumab in patients with HER2-positive early breast cancer
- (2016) Erwin De Cock et al. Cancer Medicine
- Time Savings with Rituximab Subcutaneous Injection versus Rituximab Intravenous Infusion: A Time and Motion Study in Eight Countries
- (2016) Erwin De Cock et al. PLoS One
- Role of Age-Associated Alterations of the Dermal Extracellular Matrix Microenvironment in Human Skin Aging: A Mini-Review
- (2015) Taihao Quan et al. GERONTOLOGY
- Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study
- (2014) X. Pivot et al. ANNALS OF ONCOLOGY
- Characterization of a Novel Recombinant Hyaluronan Binding Protein for Tissue Hyaluronan Detection
- (2014) Laurence Jadin et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Time Savings With Transtuzumab Subcutaneous (SC) Injection Verse Trastuzumab Intravenous (IV) Infusion: A Time and Motion Study in 3 Russian Centers
- (2014) E. De Cock et al. VALUE IN HEALTH
- Comparison of Subcutaneous and Intravenous Administration of Trastuzumab: A Phase I/Ib Trial in Healthy Male Volunteers and Patients With HER2-Positive Breast Cancer
- (2012) Chris Wynne et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Recombinant human hyaluronidase PH20 (rHuPH20) facilitates subcutaneous infusions of large volumes of immunoglobulin in a swine model
- (2012) David W. Kang et al. Drug Delivery and Translational Research
- Accelerated Insulin Pharmacokinetics and Improved Postprandial Glycemic Control in Patients With Type 1 Diabetes After Coadministration of Prandial Insulins With Hyaluronidase
- (2011) M. Hompesch et al. DIABETES CARE
- Differential hyaluronan homeostasis and expression of proteoglycans in juvenile and adult human skin
- (2010) Thrasivoulos G. Tzellos et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Hyaluronan in skin: aspects of aging and its pharmacologic modulation
- (2008) Robert Stern et al. CLINICS IN DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now